Can starting multiple kidney drugs at once slow Diabetes-Related kidney damage?

NCT ID NCT07547878

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether starting four approved kidney disease medicines quickly (over about 8 weeks) is safe and effective for people with type 2 diabetes and chronic kidney disease. Researchers will compare this rapid approach to usual care, where medicines are started one at a time. The study involves 64 participants and will track kidney function, protein in urine, and how many people can stay on all four medicines for 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Finerenone, Semaglutide, and ACE inhibitors (Benazepril, Captopril, Enalapril, Fosinopril, Lisinopril, Moexipril, Perindopril, Quinapril, Ramipril, Trandolapril)
What this could lead to
If this approach works, it could show that starting multiple kidney-protecting medicines at once is safe and helps slow kidney damage in people with diabetes.
What could go wrong
This is a small pilot study with only 64 people, so results may not apply to everyone. Starting several medicines quickly could increase side effects like high potassium or low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor Scott and White Medical Center- Temple

    Temple, Texas, 76508, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.